GMS Biotech Snags $116K SBIR Grant to Develop Blood-Transfusion Chip | GenomeWeb

By Justin Petrone

The National Institutes of Health has awarded GMS Biotech a phase I Small Business Innovation Research grant worth $115,762 to help it develop an array-based blood-screening device that the firm hopes will replace existing serological techniques used in blood banks.

Entitled "The transfusion chip: a simple, low cost microarray for DNA-based blood typing," the grant was awarded on Aug. 1 and is set to expire on Jan. 30, 2012.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.